CW January 2006Issue Number 1 January 2006 ISSN 10593802 New Drug to Avoid Severe Side Effects of Thyroid Cancer TreatmentThe use of genetically engineered thyroid stimulating hormone before adjuvant radioiodine therapy in thyroid cancer patients avoids the previous need to withhold the hormone treatment for these patients.
Go to Previous Page Go to Next Page Source & Additional Reading Journal of Clinical Endocrinology and Metabolism online edition, December 29, 2005. Purchase Downloadable Full-text PDF of Article: $10.00 Subscription is more cost effective than purchasing PDFs on-the-fly. Click here for details. Download Complete Issue CW January 2006Purchase Downloadable Full-text PDF of Complete Issue: $20.00 |
|
Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us
Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA |
Re-initialize IP-based Login |